| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 10/03/2007 | CN101045729A Method for preparing 2-arylimidazo [2,1-alpha] isoquinoline |
| 10/03/2007 | CN101045728A Preparation method and use of compound with high insecticidal activity |
| 10/03/2007 | CN100340561C Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands |
| 10/03/2007 | CN100340559C Nitrogen containing heterobicycles as factor XA inhibitors |
| 10/03/2007 | CN100340558C N,N-dipyridyl 3,4,9,10-tetraformyl diimine derirative and its synthesis method |
| 10/02/2007 | US7276524 Compounds as antumor agents or immunosuppressants |
| 10/02/2007 | US7276518 For therapy of neuropathic or chronic pain |
| 10/02/2007 | US7276517 Heterocyclic amide derivatives as inhibitors of glycogen phosphorylase |
| 10/02/2007 | US7276516 P-indolyl-, indazolyl- and pyrrolopyridyl-sulfonylbenzamides, e.g., N-(4-Fluoro-benzyl)-4-(3-phenyl-indole-1-sulfonyl)-benzamide; modulators of the Cannabinoid-1 receptor, especially useful for treating obesity |
| 10/02/2007 | US7276515 Administering optionally hydrogenated 2-alkyl-1-(alkylsulfonylalkyl)imidazo[4,5-c]quinoline-4-amines to induce biosynthesis of IFN-alpha and/or TNF-alpha; treating viral diseases and neoplastic diseases |
| 10/02/2007 | US7276514 Prevent tissue damage prevent stroke, headaches |
| 10/02/2007 | US7276511 E.g., N-{2-(3,4-dichlorophenyl)-2-[(3,3-diphenylpropionyl)-methylamino]-4-{spiro[benzo(c)thiophene-1(3H),4'-piperidine]-(2S)-oxide}-1'-yl-butyl}-3,3,3-trifluoro-N-methyl-propionamide hydrochloride, NK-1 or NK-2 receptor antagonists; used to treat irritable bowel syndrome, pain, anxiety and vomiting |
| 10/02/2007 | US7276507 Pyridopyrazines and the use thereof as kinase inhibitors |
| 10/02/2007 | CA2401229C Aryl fused azapolycyclic compounds |
| 10/02/2007 | CA2378369C Small molecules useful in the treatment of inflammatory disease |
| 10/02/2007 | CA2330756C Indole derivatives and their use for the treatment of malignant and other diseases based on pathological cell proliferation |
| 09/27/2007 | WO2007109812A2 Immunopotentiating compounds |
| 09/27/2007 | WO2007109810A2 Methods for the preparation of imidazole-containing compounds |
| 09/27/2007 | WO2007109334A2 Sip receptor modulating compounds and use thereof |
| 09/27/2007 | WO2007108936A2 N-substituted-azacyclylamines as histamine-3 antagonists |
| 09/27/2007 | WO2007108750A1 Pyridopyrimidine derivatives and their use as pde4 inhibitors |
| 09/27/2007 | WO2007107827A1 Chromane derivatives |
| 09/27/2007 | WO2007107543A1 Inhibitors of the interaction between mdm2 and p53 |
| 09/27/2007 | WO2007107352A1 Agents that disrupt cellular replication and their use in inhibiting pathological conditions |
| 09/27/2007 | WO2007107221A1 4-(pyrrolopyridinyl)pyrimidinyl-2-amine derivatives |
| 09/27/2007 | WO2007107005A1 Inhibitors of protein tyrosine kinase activity |
| 09/27/2007 | WO2007084557A3 Azaindoles useful as inhibitors of janus kinases |
| 09/27/2007 | WO2007081890A3 Production of dolasetron |
| 09/27/2007 | WO2007070589A3 Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1h-1,2,4-triazol-1-yl)-1-[(phosphonooxy)methyl]-1h-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-piperazine |
| 09/27/2007 | WO2007068728A3 N-substituted pyrrolopyridinones active as kinase inhibitors |
| 09/27/2007 | WO2007025009A3 Indenoisoquinolinone analogs and methods of use thereof |
| 09/27/2007 | WO2007002703A3 Foaming agents containing fluorine substituted unsaturated olefins |
| 09/27/2007 | WO2006096444A3 Chemical compounds |
| 09/27/2007 | US20070225319 Piperidinyl indole and tetrohydropyridinyl indole derivatives and methods of their use |
| 09/27/2007 | US20070225318 Pyrazole Compounds Useful In The Treatment Of Inflammation |
| 09/27/2007 | US20070225317 Rsv polymerase inhibitors |
| 09/27/2007 | US20070225306 Diseases with abnormal activation of the Abl, BCR-Abl, Bmx, CSK, TrkB, FGFR3, Fes, Lck, B-RAF, C-RAF, MKK6, alpha and beta SAPK2 kinases; antiproliferative; pyrrolo[2,3-d]pyrimidine-7-carboxylic acid [3-phenylcarbamoyl-phenyl]-amides and pyrrolo[3,2-c]pyridine analogs |
| 09/27/2007 | US20070225272 CGRP receptor antagonists |
| 09/27/2007 | US20070225232 Tetrahydro-Imidazo [1,5-A] Pyridyin Derivatives as Aldosterone Synthase Inhibitors |
| 09/27/2007 | US20070225167 2-Ethyl-4,6-Dimethyl-Phenyl-Substituted Tetramic Acid Derivatives as Pest Control Agents and/or Herbicides |
| 09/27/2007 | US20070222373 Naphthacene derivative and organic electroluminescent device using the same |
| 09/27/2007 | US20070221913 Aromatic imide-based dispersant for carbon nanotubes and carbon nanotube composition comprising the same |
| 09/27/2007 | DE102006012617A1 4-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate 4- (pyrrolopyridinyl) -pyrimidinyl-2-amine derivatives |
| 09/27/2007 | CA2679980A1 S1p receptor modulating compounds and use thereof |
| 09/27/2007 | CA2647100A1 Methods for the preparation of imidazole-containing compounds |
| 09/27/2007 | CA2646990A1 Foaming agents containing fluorine substituted unsaturated olefins |
| 09/27/2007 | CA2646891A1 Immunopotentiating compounds |
| 09/27/2007 | CA2646541A1 Agents that disrupt cellular replication and their use in inhibiting pathological conditions |
| 09/27/2007 | CA2646463A1 4-(pyrrolopyridinyl)pyrimidinyl-2-amine derivatives |
| 09/27/2007 | CA2645731A1 N-substituted-azacyclylamines as histamine-3 antagonists |
| 09/27/2007 | CA2645652A1 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof |
| 09/27/2007 | CA2645007A1 Chromane derivatives |
| 09/27/2007 | CA2644643A1 Inhibitors of the interaction between mdm2 and p53 |
| 09/27/2007 | CA2642452A1 Process for preparing 1-halo-2,7-naphthyridinyl derivatives |
| 09/26/2007 | EP1836204A2 Radioactive metal complexes based on bispidine and derivatives thereof |
| 09/26/2007 | EP1836203A2 Heteroaryl substituted quinolin-4-ylamine analogues |
| 09/26/2007 | EP1836188A1 Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases |
| 09/26/2007 | EP1836166A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 09/26/2007 | EP1835918A2 Inhibitors of checkpoint kinases |
| 09/26/2007 | EP1722995B1 Wheel drive |
| 09/26/2007 | EP1687293B1 Indazol-3-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (vr1) |
| 09/26/2007 | EP1539755B1 6-alkoxy-pyrido-pyrimidines as p-38 map kinase inhibitors |
| 09/26/2007 | EP1490364B1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders |
| 09/26/2007 | EP1383750B1 Urea derivatives as integrin alpha 4 antagonists |
| 09/26/2007 | EP1263726B1 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor xa |
| 09/26/2007 | CN101044140A Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| 09/26/2007 | CN101044115A Piperidines and related compounds for treatment of alzheimer's disease |
| 09/26/2007 | CN101041669A Non nucleoside reverse transcriptase inhibitors |
| 09/26/2007 | CN101041660A 1,2-dihydrogen pyridine derivative, carbon glycosides intermediate and preparation method and application thereof |
| 09/26/2007 | CN100339380C Cucurbiturils and method for synthesis |
| 09/26/2007 | CN100339377C Camptothecine derivative and its preparation |
| 09/26/2007 | CN100339080C Antiviral compounds |
| 09/25/2007 | US7273936 A 2-pyridyl derivatives therapeutic agent for treating cancer, glomerulonephritis, diabetic nephropathy, hepatic fibrosis, pulmonary fibrosis, hyperplasia, restenosis, skin disorders |
| 09/25/2007 | US7273885 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 09/25/2007 | US7273881 Bridged tricyclic (e.g., 9,10-ethanoanthracene) derivatives of (2-carbonylamino)thiazol-5-yloxoacetamides; treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF- kappa B activity including obesity, diabetes, inflammatory and immune diseases |
| 09/25/2007 | US7273878 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor |
| 09/25/2007 | US7273875 Blocking tumor necrosis factor; antiinflammatory agents; respiratory system disorders; bronchodilator |
| 09/25/2007 | US7273871 tricyclic pyridines compounds, e.g., 1-(4-methoxy-2-methylphenyl)-7-methyl-5-(1-propyl-butyl)-1,2,2a, 3,4,5-hexahydro-1,5,8-triaza-acenaphtylene; CRF antagonists used for treatment of depression, anxiety, irritable bowel disease and inflammatory bowel disease |
| 09/25/2007 | US7273868 excellent phosphodiesterase V (PDE V) inhibitory activity, and being useful as a remedy for the prophylaxis or treatment of penile erectile dysfunction with few side effects |
| 09/25/2007 | US7273867 Anticaogulants; cardiovascular disorders; Factor x inhibitors; antiinflammatory agents |
| 09/25/2007 | US7273863 Benzophenones as inhibitors of reverse transcriptase |
| 09/25/2007 | US7273861 Non-nucleoside reverse transcriptase inhibitors |
| 09/25/2007 | US7273859 Spiro-alkane, -tetrahydrofuranfuran, -tetrahydropyran, -pyrrolidine or -piperidine fused ring pyrimidinonecarboxamides, e.g., N-[(4-fluorophenyl)methyl]-7',8'-dihydro-3'-hydroxy-4'-oxo-spiro[cyclopentane-21,9'(6'H)-[4H]pyrido[1,2- alpha ]pyrimidine]-2'-carboxamide |
| 09/25/2007 | CA2306257C 5-azaquinoxaline-based compounds and modulation of serine/threonine protein kinase function |
| 09/25/2007 | CA2229077C Lipid metabolism improving agent |
| 09/20/2007 | WO2007106236A2 Pyrrolo-pyridine kinase modulators |
| 09/20/2007 | WO2007105751A1 Quinolone derivative or pharmaceutically acceptable salt thereof |
| 09/20/2007 | WO2007105154A2 Antibiotic compounds |
| 09/20/2007 | WO2007105049A1 Dibenzyl amine derivatives as cetp inhibitors |
| 09/20/2007 | WO2007104714A1 Spiroindolinone derivatives |
| 09/20/2007 | WO2007104664A1 Spiroindolinone derivatives |
| 09/20/2007 | WO2007104558A1 Thiazoles as nf-kb inhibitors (proteasome inhibitors) |
| 09/20/2007 | WO2007104538A1 Heterobicyclic carboxamides as inhibitors for kinases |
| 09/20/2007 | WO2007104135A1 Bifunctional polyazamacrocyclic chelating agents |
| 09/20/2007 | WO2007084390A3 Histone deacetylase inhibitors |
| 09/20/2007 | WO2007081889A9 Production of dolasetron |
| 09/20/2007 | WO2007081517A8 Anti-viral compounds |
| 09/20/2007 | WO2007074491A8 HETEROTRICYCLIC AMIDE DERIVATIVES AS NEUROKININ-l (NKl) RECEPTOR LIGANDS |
| 09/20/2007 | US20070219237 Chromane Derivatives |
| 09/20/2007 | US20070219236 Dialkoxy-Imidazopyridines Derivatives |